A self-report instrument that describes urogenital atrophy symptoms in breast cancer survivors

Western Journal of Nursing Research

Volumn 34, Issue 1, 2012, Pages 72-96

  Lester, Joanne ^a,b   Bernhard, Linda ^b   Ryan Wenger, Nancy ^a,c  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

atrophic vaginitis; breast cancer; incontinence; sexuality; urogenital atrophy; vaginal dryness

Indexed keywords

ADULT; AGED; ARTICLE; ATROPHIC VAGINITIS; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HEALTH SURVEY; HUMAN; METHODOLOGY; MIDDLE AGED; NURSING; SELF REPORT; SEXUALITY; STANDARD; SURVIVOR; URINE INCONTINENCE; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; ATROPHIC VAGINITIS; BREAST NEOPLASMS; FEMALE; HEALTH SURVEYS; HUMANS; MIDDLE AGED; SELF REPORT; SEXUALITY; SURVIVORS; URINARY INCONTINENCE; YOUNG ADULT;

EID: 84855603546     PISSN: 01939459     EISSN: 15528456     Source Type: Journal    
DOI: 10.1177/0193945910391483     Document Type: Article

References (34)

1. Alfano C. M.,McGregor B. A.,Kuniyuki A.,Reeve B. B.,Bowen D. J.,Baumgartner K. B.,McTiernan A.Psychometric properties of a tool for measuring hormone-related symptoms in breast cancer survivors.Psycho-Oncology. 2006;15:985-1000.
2. Atkins L.,Fallowfield L. J.Fallowfield's Sexual Activity Questionnaire in women with, without and at risk of cancer.Menopause International. 2007;13:103-109.
3. Avis N. E.,Crawford S.,Manuel J.Quality of life among younger women with breast cancer.Journal of Clinical Oncology. 2005;23:3322-3330.
4. Barni S.,Mondin R.Sexual dysfunction in treated breast cancer patients.Annals of Oncology. 1997;8:1-5.
5. Boekhout A. H.,Beijnen J. H.,Schellens J. H. M.Symptoms and treatment in cancer therapy-induced early menopause.Oncologist. 2006;11:641-654.
6. Broeckel J. A.,Thors C. L.,Jacobsen P. B.,Small M.,Cox C. E.Sexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapy.Breast Cancer Research and Treatment. 2002;75:241-248.
7. Cella D.,Fallowfield L. J.Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.Breast Cancer Research and Treatment. 2008;107:167-180.
8. Conde D. M.,Pinto-Neto A. M.,Cabello C.,Sa D. S.,Costa-Paiva L.,Martinez E. D.Menopause symptoms and quality of life in women aged 45-65 years with and without breast cancer.Menopause. 2005;12:436-443.
9. Coyne K.,Revicki D.,Hunt T.,Corey R.,Stewart W.,Bentkover J.,Abrams P.Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q.Quality of Life Research. 2002;11:563-574.
10. Daker-White G.Reliable and valid self-report outcome measures in sexual (dys)function: A systematic review.Archives of Sexual Behavior. 2002;31:197-209.
11. Davidson, S. B., & Grant, M. M. (2004). Assessing vaginitis. In M. Frank-Stromberg & S. J. Olsen (Eds.), Instruments for clinical health-care research (3rd ed., pp. 663-682). Sudbury, MA: Jones and Bartlett.
12. DeRogatis L. R.Assessment of sexual function/dysfunction via patient reported outcomes.International Journal of Impotence Research. 2008;20:35-44.
13. Fallowfield L. J.,Leaity S. K.,Howell A.,Benson S.,Cella D.Assessment of quality of life in women undergoing hormonal therapy for breast cancer: Validation of an endocrine symptom subscale from FACT-B.Breast Cancer Research and Treatment. 1999;55:189-199.
14. Ganz P. A.,Desmond K. A.,Belin T. R.,Meyerowitz B. E.,Rowland J. H.Predictors of sexual health in women after a breast cancer diagnosis.Journal of Clinical Oncology. 1999;17:2371-2380.
15. Grant M.,Davidson S.Effects of perineal care on diabetic vulvovaginitis: Final report of project. Washington, DC: Division of Nursing, Bureau of Health Manpower, Health Resources Administration, Department of Health and Human Resources; 1984:.
16. Gupta P.,Sturdee D. W.,Palin S. L.,Majumder K.,Fear R.,Marshall T.,Paterson I.Menopausal symptoms in women treated for breast cancer: The prevalence and severity of symptoms and their perceived effects on quality of life.Climacteric. 2006;9:49-58.
17. Huber C.,Ramnarace T.,McCaffrey R.Sexuality and intimacy issues facing women with breast cancer.Oncology Nursing Forum. 2006;33:1163-1167.
18. Jemal A.,Siegel R.,Xu J,Ward E.Cancer statistics 2010.CA: A Cancer Journal for Clinicians. 2010;60:277-300.
19. Kelley C.Estrogen and its effect on vaginal atrophy in post-menopausal women.Urologic Nursing. 2007;27:40-45.
20. Kirkova J.,Davis M. P.,Walsh D.,Tiernan E.,O'Leary N.,LeGrand S. B.,Russell K. M.Cancer symptom assessment instruments: A systematic review.Journal of Clinical Oncology. 2006;24:1459-1473.
21. Lenz, E. R., & Pugh, L. C. (2003). The theory of unpleasant symptoms. In M. J. Smith & P. Liehr (Eds.), Middle range theory for nursing (pp. 69-90). New York, NY: Springer.
22. Lester J.,Bernhard L.Urogenital atrophy in breast cancer survivors.Oncology Nursing Forum. 2009;36:693-698.
23. LesterJ. L. (2008). Development of a self-report instrument for use in the clinical setting that describes symptoms related to urogenital atrophy in women with breast cancer (Unpublished dissertation). The Ohio State University, Columbus.
24. Lowe N. K.,Ryan-Wenger N. A.A clinical test of women's self-diagnosis of genitourinary infections.Clinical Nursing Research. 2000;9:144-160.
25. Lynn M. R.Determination and quantification of content validity.Nursing Research. 1986;35:382-385.
26. McKenna S. P.,Whalley D.,Renck-Hooper U.,Carlin S.,Doward L. C.The development of quality of life instrument for use with postmenopausal women with urogenital atrophy in the UK and Sweden.Quality of Life Research. 1999;8:393-339.
27. Munro B. H.Statistical methods for health care research. 2005). Statistical methods for health care research (5th ed.). Philadelphia, PA: Lippincott, Williams, & Wilkins.Philadelphia, PA: Lippincott, Williams, & Wilkins; 2005:.
28. Nunnally J. C.,Bernstein I. H.Psychometric testing. 1994). Psychometric testing (3rd ed.). New York, NY: McGraw-Hill.New York, NY: McGraw-Hill; 1994:.
29. Pett M. A,Lackey N. R.,Sullivan J. J.Making sense of factor analysis: The use of factor analysis for instrument development in health care research. Thousand Oaks, CA: Sage; 2003:.
30. Rosen R.,Brown C.,Heiman J.,Leiblum S.,Meston C.,Shabsigh R.,Agostino R.The female sexual function index (FSFI): A multi-dimensional self-report instrument for the assessment of female sexual function.Journal of Sex & Marital Therapy. 2000;26:191-208.
31. Speer J.,Hillenberg B.,Sugrue D. P.,Blacker C.,Kresge C. L.,Decker V.,Decker D. A.Study of sexual functioning determinants in breast cancer survivors.Breast Journal. 2005;11:440-447.
32. Stanton A. L.,Bernaards C. A.,Ganz P. A.The BCPT Symptom Scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer.Journal of the National Cancer Institute. 2005;97:448-456.
33. Willhite L. A.,O'Connell M. B.Urogenital atrophy: Prevention and treatment.Pharmacotherapy. 2001;21:464-480.
34. Zibecchi L.,Greendale G. A.,Ganz P. A.Comprehensive menopausal assessment: An approach to managing vasomotor and urogenital symptoms in breast cancer survivors.Oncology Nursing Forum. 2003;30:393-407.